SEATTLE, Feb. 25, 2014 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) announced today that it will report its fourth quarter and full year 2013 financial results on Tuesday, March 4, 2014, after the close of the U.S. financial markets. Following the announcement, members of the management team will host a webcast conference call to discuss the results and provide a general corporate update at 4:30 p.m. ET ( 1:30 p.m. PT). Access to the event can be obtained as follows: Tuesday, March 41:30 p.m. PT/ 4:30 p.m. ET/ 10:30 p.m. CET1-800-762- 8779 (domestic) +1 480-629-9771 (international) To access the live audio webcast or the subsequent archived recording, visit CTI's website, www.celltherapeutics.com. Webcast and telephone replays of the conference call will be available at approximately two hours after completion of the call. Callers can access the replay by dialing 1-800-406-7325 (domestic) or +1 303-590-3030 (international). The access code for the replay is #4670750. The telephone replay will be available until Tuesday, March 11, 2014. About Cell Therapeutics, Inc. CTI (NASDAQ and MTA: CTIC) is a biopharmaceutical company committed to the development and commercialization of an integrated portfolio of oncology products aimed at making cancer more treatable. CTI is headquartered in Seattle, WA. For additional information and to sign up for email alerts and get RSS feeds, please visit www.CellTherapeutics.com. Contacts: Monique Greer+1 206-272-4343 firstname.lastname@example.orgEd Bell+1 206-282-7100 email@example.com In Europe: CTI Life Sciences Limited, Milan BranchLaura Villa +39 02 89659706 firstname.lastname@example.orgCTI_EUInvestors@CTI-Lifesciences.com SOURCE Cell Therapeutics, Inc.